High Dose Interferon Therapy and Natural Killer Cell Activity
Author Information
Author(s): B. Tank, R.L. Marquet, W. Weimar, D.L. Westbroek
Primary Institution: Erasmus University
Hypothesis
High dose recombinant alpha 2 interferon therapy affects natural killer cell activity in patients with colorectal carcinoma.
Conclusion
High dose interferon therapy initially increases natural killer cell activity but leads to a subsequent depression in activity.
Supporting Evidence
- Interferon therapy initially increased natural killer cell activity in patients.
- After the initial increase, natural killer cell activity decreased significantly.
- One patient showed near total regression of a liver metastasis after treatment.
Takeaway
Doctors gave a medicine called interferon to patients to see how it affected their immune cells, and they found that it made the cells work better at first but then made them less effective later.
Methodology
Patients received high dose interferon therapy, and their natural killer cell activity was measured at various time points.
Limitations
The study involved a small sample size and was limited to patients with colorectal carcinoma.
Participant Demographics
Six female and four male patients aged 49-77 years with resected colorectal carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website